Galantamine
4 sources
How the databases line up — = agree, ≈ partial, ≠ differ. In lists, shared items appear in every source and unique ones in only one (matched case-insensitively).
Show:
| PsychonautWiki | Pharmacology | DrugCentral | DailyMed | ||
|---|---|---|---|---|---|
| Classification | |||||
| Class / category | — | — | — | ||
| Also known as | Galantamine | — | — | — | |
| Safety | |||||
| Addiction potential | not habit-forming | — | — | — | |
| Toxicity | extremely low toxicity | — | — | — | |
| Dose · Oral | |||||
| Threshold | 1 mg | — | — | — | |
| Light | 4–8 mg | — | — | — | |
| Common | 8–16 mg | — | — | — | |
| Strong | 16–24 mg | — | — | — | |
| Heavy | 24 mg+ | — | — | — | |
| Duration | |||||
| Onset | 20–60 minutes | — | — | — | |
| Total | 6–12 hours | — | — | — | |
| Pharmacology | |||||
| Receptor activity | — | AcetylcholinesteraseCholinesteraseButyrylcholinesteraseUncheckedGlutamate receptor ionotropic, NMDA 2B | ACHEBCHE | — | ≠ |
| Half-life | — | Galantamine has a terminal half-life of about 7 hours. Elimination half-life: 7 hours | — | — | |
| Protein binding | — | The plasma protein binding of galantamine is 18% at therapeutically relevant concentrations. | — | — | |
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.